Patents by Inventor Zhanghua CHEN

Zhanghua CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240069436
    Abstract: A method for building an etching-free hybrid nonlinear waveguide composed of a polymer and an ion-implanted nonlinear crystal is provided. A nonlinear crystal is pretreated, and subjected to ion implantation to obtain an ion-implanted nonlinear crystal. The ion-implanted nonlinear crystal is spin-coated with a photoresist, and subjected to electron beam exposure, heating, and developing, so as to obtain a hybrid optical waveguide composed of a polymer and a nonlinear crystal.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Inventors: Chen CHEN, Zhanghua HAN, Shengkun YAO, Feng CHEN
  • Publication number: 20240067683
    Abstract: The present disclosure relates to the field of biomedicine, in particular to the use of MCM8-cGAS-STING-IFN-I signal pathway as a disease target, including the use in the preparation of an animal model of a disease or the preparation of a product for the diagnosis, prevention, or treatment of a disease. In particular, the present disclosure comprises the use of a reagent for quantitatively detecting the gene expression or protein expression or protein activity of MCM8 in the preparation of a product for the diagnosis of a disease caused by dysfunctional mitophagy or caused by abnormal activation of cGAS-STING-IFN-I signaling pathway.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 29, 2024
    Inventors: Yuxia Zhang, Meng Lin, Huifang Xian, Zhanghua Chen, Fan Bai, Jun Cui, Xiaoqiong Gu
  • Publication number: 20230111925
    Abstract: The present invention relates to a fibrotic disease mechanism, and a preventive/therapeutic drug and method therefor. The present invention can improve the level of cAMP by means of a PDE inhibitor such as dipyridamole to treat fibrotic diseases and inhibit the progress of fibrosis. The present invention further achieves anti-inflammatory and immune regulation effects, and achieves a therapeutic effect on all aspects of the occurrence and development of fibrosis.
    Type: Application
    Filed: February 9, 2021
    Publication date: April 13, 2023
    Applicant: GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
    Inventors: Yuxia ZHANG, Yanhui XU, Bing HUANG, Ming LIU, Zhiyao ZHAO, Jun WANG, Zhanghua CHEN, Rongli FANG
  • Publication number: 20220260566
    Abstract: The present invention relates to gastrointestinal diseases, such as non-infectious gastrointestinal diseases, including the immune mechanism of non-infectious gastrointestinal diseases in children, and the use of phosphodiesterase inhibitors and/or antiplatelet drugs in the treatment of gastrointestinal diseases such as non-infectious gastrointestinal diseases.
    Type: Application
    Filed: November 15, 2019
    Publication date: August 18, 2022
    Applicant: GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
    Inventors: Yuxia ZHANG, Min YANG, Bing HUANG, Zhanghua CHEN, Li ZHANG, Fan BAI, Sitang GONG